Cochlear Implantation in Pediatric Cases of Unilateral Hearing Loss

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-04-20

Study Completion Date

2021-05-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This feasibility study evaluates whether children with unilateral, moderate to profound sensorineural hearing loss experience an improvement in speech perception, hearing in noise, localization, and quality of life with a cochlear implant as compared to an unaided listening condition.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Outcomes in Children With Pre-operative Residual Hearing

NCT03379870

High Frequency Sensorineural Hearing Impairment Hearing Disorders in Children

COMPLETED NA

Single-Sided Deafness in the Medicare Population

NCT05250414

Hearing Loss, Unilateral

COMPLETED NA

Cochlear Implantation for Treatment of Single-sided Deafness

NCT02532972

Total Unilateral Deafness Unilateral Partial Deafness

TERMINATED NA

Cochlear Implantation for Young Single-sided Deaf Children

NCT04738968

Deafness Unilateral

ACTIVE_NOT_RECRUITING NA

Single-sided Deafness and Cochlear Implants

NCT01749592

Sensorineural Hearing Loss (Disorder)

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Unilateral hearing loss (UHL) is a term used to describe a substantial hearing loss in one ear and normal hearing in the contralateral ear. Despite normal hearing in one ear, these individuals experience reduced speech perception in noise, variable abilities on localization tasks, increased reports of hearing handicap, reduced quality of life, and often, they obtain limited or no benefit from conventional amplification. In the United States, the prevalence of UHL in children ranges from 0.03% to 3%, depending on the age of the child.

Cochlear implantation performed for children with bilateral, severe to profound deafness has significant impacts on several aspects of child development.

The practice of providing cochlear implants to children who have significant hearing loss in one ear is of great interest and is occurring with greater frequency as reported in case studies and small set clinical reports. The primary purpose of this feasibility study is to demonstrate the effectiveness of cochlear implantation in children, age 3 years 6 months to 6 years, 6 months, with moderate to profound UHL. Postoperative results will be evaluated with speech perception measures, localization tasks, hearing in noise tasks, and subjective reports.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hearing Loss, Unilateral

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cochlear Implant

Pediatric patients with single sided deafness will receive a cochlear implant in the ear of loss

Group Type EXPERIMENTAL

Cochlear implant

Intervention Type DEVICE

Implantation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cochlear implant

Implantation

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

MED-EL Cochlear Implant MED-EL Synchrony with FLEX 28 array MED-EL Synchrony with FLEX 24 array

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Unilateral moderate-to-profound sensorineural hearing loss.

1. Unaided residual hearing thresholds that yield a pure tone average (PTA) at frequencies 500 Hz, 1 kHz and 2 kHz of ≥70 dB HL in the ear to be implanted. It is possible that subjects may have hearing at other frequencies not included in this average.
2. Hearing thresholds in the contralateral ear of ≤25 dB HL
2. Between 3 years, 6 mos and 6 years, 6 mos of age at implantation.
3. Anatomically normal cochlear nerve
4. Cochlear anatomy that is amenable to cochlear implantation as evaluated by imaging (modality at the physician's discretion) including:

1. Normal cochlear anatomy or
2. Incomplete Partition Type II (IP2) with or without Enlarged Vestibular Aqueduct (EVA) or
3. EVA with normal partitioning
5. No evidence of progressive hearing loss.
6. Willing to undergo 4 week hearing aid trial as warranted based on achieving desired audibility when fitted via real ear desired sensation level (DSL) method.
7. Aided word recognition in the ear to be implanted of 30% or less as measured with Consonant Nucleus Consonant (CNC) words (50-word list)

1. When listening with an appropriately fit hearing aid and masking applied to the contralateral ear (Turner, 2004).
2. Aided testing will be conducted in a sound-proof booth with the participant seated 1 meter from the sound source, facing 0° azimuth. Recorded materials will be presented at 60 dB SPL.
3. The hearing aid output will be measured using DSL targets.
8. Realistic parental expectations: a verbal acknowledgement of the potential benefits and risks, and postoperative variation in performance. For instance, cochlear implantation will not restore normal hearing.
9. Willing to obtain recommended meningitis vaccinations per CDC recommendations.

(9) Development and cognition within the normal range as measured by the Leiter-R test of nonverbal intelligence and cognitive abilities and the Bracken Basic Concept Scale -Revised.

(10) Parental commitment to study parameters including being able and willing to participate in evaluation schedule, involvement in prescribed therapy, and travel to investigational site and study-related activities.

Exclusion Criteria

1. English is not primary language of the home

1. Speech perception materials are presented in English
2. Parental questionnaires are administered in English
2. Conductive hearing loss in either ear
3. Compromised auditory nerve
4. Ossification of the cochlea
5. Inability to participate in follow-up procedures (i.e., unwillingness, geographic location)
6. History of condition that contraindicates middle or inner ear surgery or anesthesia (i.e. otitis media refractory to treatment)
7. Case of sudden sensorineural hearing loss that has not been first evaluated by a physician

Minimum Eligible Age

42 Months

Maximum Eligible Age

78 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes